Olmesartan HCT AN 20/25 olmesartan medoxomil/hydrochlorothiazide 20/25 mg film coated tablets blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

hydrochlorothiazide, Quantity: 25 mg; olmesartan medoxomil, Quantity: 20 mg

Disponibbli minn:

Amneal Pharma Australia Pty Ltd

INN (Isem Internazzjonali):

Hydrochlorothiazide,Olmesartan medoxomil

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; purified water; hyprolose; hypromellose; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 4000

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

30

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Indicated for the treatment of hypertension.,Treatment should not be initiated with this fixed dose combination.

Sommarju tal-prodott:

Visual Identification: 20/25 mg film coated tablets are yellow film coated, oval shaped, biconvex tablets debossed with L400 on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2015-02-05